AI Article Synopsis
- Magnetic resonance spectroscopy (MRS) is a non-invasive technique that helps analyze the chemical makeup of prostate tissue.
- MRS can differentiate between healthy prostate tissue and carcinomas by profiling metabolites like choline, citrate, creatine, and myo-inositol.
- The ratios of these metabolites serve as potential biomarkers for identifying malignant areas within the prostate gland.
Article Abstract
Magnetic resonance spectroscopy (MRS) is a prospective tool for characterization of the chemical composition of tissues. In vivo MRS can be used for metabolite profiling in the prostate tissue to discriminate non-invasively carcinomas and healthy prostate. In this article different prostate metabolites have been discussed and how to exploit the MRS technique for the estimation of metabolites in prostate tissue quantitatively is elucidated. Choline, citrate, creatine, myo-inositol metabolites can be considered as biomarker for localization of malignancy in the prostate and their ratio can be used for the determination of cancer tissue in the prostate gland.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2741/4275 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!